skip to main content

Breast Lump on Immunosuppression — SCE Rheumatology MCQ

Instant feedback + full explanation. One question, done properly.

HardRheumatology EmergenciesBreast Lump on ImmunosuppressionSCE Rheumatology

A patient with rheumatoid arthritis taking adalimumab has a breast lesion highly suspicious for malignancy and is awaiting urgent biopsy. What is the safest medication principle?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: C — Coordinate an individual treatment plan with rheumatology and the breast team

Suspected malignancy needs urgent diagnostic assessment without delay for an arbitrary biologic washout. Immunosuppressive treatment should be reviewed jointly, considering infection, surgery, tumour type and flare risk. A universal instruction either to continue or permanently stop therapy is unsafe.

Reference: https://www.nice.org.uk/guidance/conditions-and-diseases/musculoskeletal-conditions